QR kód

How to optimize the CAR-T Cell therapy process? A group concept mapping analysis of preconditions for a frictionless process from a German multistakeholder perspective

IntroductionTreatment with chimeric antigen receptor T (CAR-T) cells involves a large number of interdisciplinary stakeholders and is associated with complex processes ranging from patient-specific production to follow-up care. Due to the complexity, maximum process optimization is required in order...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Ann-Cathrine Siefen, Melina Sophie Kurte, Florian Jakobs, Marcel Teichert, Bastian von Tresckow, Hans Christian Reinhardt, Udo Holtick, Johannes Atta, Christian Jehn, Elisa Sala, Anke Warnecke, Mathias Hänel, Christof Scheid, Florian Kron
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2024-09-01
Edice:Frontiers in Oncology
Témata:
On-line přístup:https://www.frontiersin.org/articles/10.3389/fonc.2024.1466803/full
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!